Pune, India -- (SBWIRE) -- 03/19/2018 -- MarketResearchFuture.com published a Half-Cooked research report on "Global Pulmonary Edema Market Research Report - Forecast to 2023" reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5607 .

The global pulmonary edema market is expected to grow at an approximate CAGR of 7.2% during the forecast period.

The report titled "Pulmonary Edema Market -Forecast to 2023? is a direct appreciation by Market Research Future of the market potential of the Pulmonary Edema. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today's winner takes all market!

Regional Analysis:

America dominates the global pulmonary edema market due to the presence of a well-developed healthcare sector, high per capita healthcare expenditure and developed economies such as the U.S. and Canada within the region. Additionally, global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the region boost the market. Europe holds the second major market for pulmonary edema, followed by the Asia Pacific owing to the availability of funds for research and presence of developed economies like France, Italy, Germany within the region along with the growing geriatric population. Asia Pacific is the fastest growing region for the global pulmonary edema market due to rising healthcare expenditure, favorable government policies, and huge patient population. The Middle East & Africa has the least share in the global pulmonary edema market. Presence of poor economies and stringent government policies especially within in the African region retains the regional market growth. A majority of the market in the region is held by the Middle East due to huge healthcare expenditure and presence of developed healthcare sector.

Key Players:

Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), others.

Market Highlights:

Increasing prevalence of pulmonary edema and diseases like kidney failure, heart diseases, and others along with the growing geriatric population boosts the market growth. On the other hand, low per capita healthcare expenditure in the middle and low-income countries, and lack of awareness about the disease are estimated to restrain the market growth.

According to the National Kidney Foundation in 2015, about 10% of the world's total population is estimated to be affected by chronic kidney diseases (CKD). Moreover, it is estimated that millions of patients diagnosed with the disease die every year due to unaffordability for treatment. Additionally, growing geriatric population boosts the market growth. However, low per capita healthcare expenditure in the middle and low-income countries followed by the lack of awareness is projected to restrain the market growth.

ACCESS COMPLETE REPORT@ https://www.marketresearchfuture.com/reports/pulmonary-edema-market-5607 .

Segmentation:
The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others. On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others. The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others. On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

MAJOR TABLE OF CONTENT:
Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition

2.2 Scope Of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

…CONTINUED

AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/5607 .

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com